HDAC6-Catalyzed α-Tubulin Lactylation: Connecting Cellular Metabolism and Microtubule Function

Study Background and Research Question

Microtubules, composed of α/β-tubulin heterodimers, are critical cytoskeletal elements facilitating intracellular transport, cell division, and neuronal development. Their dynamic nature—characterized by cycles of polymerization and depolymerization—enables specialized cellular processes, including neurite extension and mitosis. Regulation of microtubule behavior is mediated in part by post-translational modifications (PTMs) of tubulin, a phenomenon described as the “tubulin code.” While modifications such as acetylation at lysine 40 (K40) of α-tubulin have been well-studied, the full spectrum and functional consequences of tubulin PTMs remain incompletely understood. The reference study sought to investigate whether α-tubulin undergoes additional, previously uncharacterized PTMs that could influence microtubule dynamics, particularly in the context of metabolic state and neuronal function (DOI:10.1038/s41467-024-52729-0).

Key Innovation from the Reference Study

The primary innovation reported is the identification of α-tubulin lactylation at K40, a modification catalyzed directly by the deacetylase HDAC6 in response to elevated intracellular lactate. This lactylation increases microtubule dynamics, facilitating neurite outgrowth and branching in cultured hippocampal neurons. Notably, the study demonstrates that HDAC6, previously known for its deacetylase activity, also acts as a “writer” of lactylation on α-tubulin, revealing a new axis by which cellular metabolism (specifically, glycolysis-derived lactate) can directly regulate cytoskeletal architecture (DOI:10.1038/s41467-024-52729-0).

Methods and Experimental Design Insights

The researchers combined advanced mass spectrometry, site-directed mutagenesis, and in vitro reconstitution assays to establish the presence and functional impact of α-tubulin lactylation. Key methodological steps included:

• Identification of lactylation at K40 of α-tubulin in soluble tubulin dimers using mass spectrometry.
• Use of cultured hippocampal neurons to assess the impact of lactylated tubulin on microtubule dynamics, neurite outgrowth, and branching.
• Manipulation of intracellular lactate levels to modulate lactylation, confirming the metabolic sensitivity of the modification.
• Loss-of-function and rescue experiments with HDAC6 to demonstrate its necessity and sufficiency for α-tubulin lactylation.
• Biochemical assays to confirm the reversibility and conservation of the lactylation mechanism among HDAC family proteins.

This multi-pronged approach enabled the authors to delineate both the enzymatic machinery and the physiological consequences of α-tubulin lactylation (DOI:10.1038/s41467-024-52729-0).

Core Findings and Why They Matter

• Discovery of α-Tubulin Lactylation: The study conclusively identifies lysine 40 on α-tubulin as a site of lactylation. This modification is found predominantly in soluble tubulin dimers, distinguishing it from acetylation, which is enriched in stable, polymerized microtubules.
• HDAC6 as a Metabolic Sensor and Writer: HDAC6, long characterized as a deacetylase, is shown to catalyze the addition of lactyl groups to α-tubulin in a lactate-dependent manner. This function is reversible and conserved across HDAC family members, linking metabolic flux to microtubule regulation.
• Functional Impact on Microtubule Dynamics: Lactylated α-tubulin increases microtubule dynamics, as evidenced by enhanced neurite outgrowth and branching in cultured neurons. This PTM effectively competes with acetylation at the same residue, suggesting a dynamic regulatory interplay between these modifications.
• Integration of Metabolic and Structural Cellular Programs: By demonstrating that glycolysis-derived lactate can directly alter cytoskeleton behavior via HDAC6-mediated tubulin lactylation, the study establishes a mechanistic link between cellular energy metabolism and the physical properties of neuronal architecture.

These findings have broad implications for understanding how neuronal structure and plasticity are modulated in response to metabolic cues, with potential relevance in neurodevelopmental and neurodegenerative disease contexts (DOI:10.1038/s41467-024-52729-0).

Comparison with Existing Internal Articles

Several internal resources provide complementary insights into microtubule regulation, particularly in the context of cancer research and pharmacological modulation. For example, the article "Paclitaxel (Taxol): Mechanistic Mastery and Strategic Frontiers" discusses how paclitaxel acts as a microtubule polymer stabilizer to arrest the cell cycle at the G2-M phase, a mechanism leveraged in cancer biology. Similarly, "Paclitaxel (Taxol) as a Microtubule Dynamics Modulator" explores advanced experimental strategies for evaluating microtubule-targeting agents. The present reference study diverges from these pharmacological approaches by uncovering an endogenous, metabolically regulated mechanism for modulating microtubule dynamics in neurons, rather than in cancer cells. However, the mechanistic insights regarding competition between stabilizing and destabilizing PTMs (e.g., acetylation, lactylation) can inform experimental design for both oncology and neuroscience researchers investigating microtubule function and cell cycle regulation.

Protocol Parameters

• neuronal culture assay | 0.01–1.0 μmol/L paclitaxel | in vitro microtubule stabilization | To probe microtubule response to polymerization stabilization | product_spec
• neurite outgrowth assay | lactate supplementation, variable mM | assess lactylation impact on microtubules | To test metabolic modulation of cytoskeleton | workflow_recommendation
• animal model, IV dosing | 12.5 mg/kg paclitaxel | tumor angiogenesis inhibition | To benchmark microtubule stabilization in vivo | product_spec
• mass spectrometry PTM mapping | site-specific peptide enrichment | PTM discovery/validation | To identify and quantify α-tubulin lactylation | paper

Limitations and Transferability

The findings are primarily derived from in vitro neuronal cultures and biochemical assays, with functional validation focused on neurite outgrowth and microtubule behavior in neurons. While the identification of HDAC6-catalyzed lactylation is robust, the direct physiological roles of this PTM in vivo, particularly in non-neuronal contexts or disease states, require further exploration. The interplay between competing modifications (acetylation vs. lactylation) may differ across cell types, and potential translational relevance for cancer research or other pathologies remains to be systematically evaluated (DOI:10.1038/s41467-024-52729-0).

Research Support Resources

Researchers aiming to dissect microtubule dynamics or to benchmark the effects of endogenous PTMs against pharmacological stabilization can utilize Paclitaxel (Taxol) (SKU A4393) as a reference microtubule polymer stabilizer. Paclitaxel’s well-characterized bioactivity—including cell cycle arrest at the G2-M phase and its compatibility with both in vitro and in vivo models—makes it a valuable standard for comparative studies on cytoskeletal modulation (source: product_spec). For further guidance on experimental strategies, see the internal article "Paclitaxel (Taxol): Microtubule Polymer Stabilizer in Advanced Oncology".